Tapewire

Nasdaq · USD

NRIX

Nurix Therapeutics, Inc.

Export transactions ↓
Tapewire entity
1156
SEC CIK
0001549595
Parsed reports
268

Last 12 months

Inside the activity.

0 purchase rows · 39 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202502
Jan 202607
Feb 202601
Mar 202601
Apr 202604
May 202604
Jun 202603
Jul 202604
Aug 202606
Sep 202603
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 10, 2021 Filed Mar 11, 2021 22:35 UTC
Ring ChristineGeneral Counsel
SaleCommon Stock 395 $44.11 $17,424.64
Disclosure

SEC source: 0001209191-21-019870 · doc4.xml · nonDerivative · entry 5

Ring Christine · CIK 0001817199 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 805

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F6 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $43.59 and the highest price at which shares were sold was $44.31.

F2 · balance_after: Includes 805 shares of Common Stock acquired by the Reporting Person on February 12, 2021 pursuant to the Issuer's employee stock purchase plan.

Read SEC document
March 10, 2021 Filed Mar 11, 2021 22:35 UTC
Ring ChristineGeneral Counsel
SaleCommon Stock 405 $42.67 $17,279.73
Disclosure

SEC source: 0001209191-21-019870 · doc4.xml · nonDerivative · entry 4

Ring Christine · CIK 0001817199 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,200

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F5 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $42.15 and the highest price at which shares were sold was $43.15.

F2 · balance_after: Includes 805 shares of Common Stock acquired by the Reporting Person on February 12, 2021 pursuant to the Issuer's employee stock purchase plan.

Read SEC document
March 10, 2021 Filed Mar 11, 2021 22:35 UTC
Ring ChristineGeneral Counsel
SaleCommon Stock 300 $41.13 $12,339.00
Disclosure

SEC source: 0001209191-21-019870 · doc4.xml · nonDerivative · entry 3

Ring Christine · CIK 0001817199 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,605

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F4 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $40.99 and the highest price at which shares were sold was $41.30.

F2 · balance_after: Includes 805 shares of Common Stock acquired by the Reporting Person on February 12, 2021 pursuant to the Issuer's employee stock purchase plan.

Read SEC document
March 10, 2021 Filed Mar 11, 2021 22:35 UTC
Ring ChristineGeneral Counsel
SaleCommon Stock 900 $39.44 $35,496.00
Disclosure

SEC source: 0001209191-21-019870 · doc4.xml · nonDerivative · entry 2

Ring Christine · CIK 0001817199 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,905

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F3 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $39.39 and the highest price at which shares were sold was $39.84. The reporting person undertakes to provide upon request to the staff of the Securities Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the ranges set forth in footnotes (3), (4), (5) and (6) to this Form 4.

F2 · balance_after: Includes 805 shares of Common Stock acquired by the Reporting Person on February 12, 2021 pursuant to the Issuer's employee stock purchase plan.

Read SEC document
March 10, 2021 Filed Mar 11, 2021 22:35 UTC
Ring ChristineGeneral Counsel
Exercise / conversionCommon Stock 2,000 $1.86 $3,720.00
Disclosure

SEC source: 0001209191-21-019870 · doc4.xml · nonDerivative · entry 1

Ring Christine · CIK 0001817199 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,805

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2 · balance_after: Includes 805 shares of Common Stock acquired by the Reporting Person on February 12, 2021 pursuant to the Issuer's employee stock purchase plan.

Read SEC document
March 08, 2021 Filed Mar 9, 2021 16:04 UTC
Beaurang PierreChief Business Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 7,500 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001209191-21-018935 · doc4.xml · derivative · entry 6

Beaurang Pierre · CIK 0001817226 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,726

Underlying: Common Stock · 7,500 shares

Expires 2026-01-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F6 · derivative.exercise_date: The option is fully vested.

Read SEC document
March 08, 2021 Filed Mar 9, 2021 16:04 UTC
Beaurang PierreChief Business Officer
SaleCommon Stock 200 $38.34 $7,668.00
Disclosure

SEC source: 0001209191-21-018935 · doc4.xml · nonDerivative · entry 4

Beaurang Pierre · CIK 0001817226 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F4 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $38.23 and the highest price at which shares were sold was $38.45.

Read SEC document
March 08, 2021 Filed Mar 9, 2021 16:04 UTC
Beaurang PierreChief Business Officer
SaleCommon Stock 4,490 $37.31 $167,503.94
Disclosure

SEC source: 0001209191-21-018935 · doc4.xml · nonDerivative · entry 3

Beaurang Pierre · CIK 0001817226 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F3 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $36.94 and the highest price at which shares were sold was $37.63.

Read SEC document
March 08, 2021 Filed Mar 9, 2021 16:04 UTC
Beaurang PierreChief Business Officer
SaleCommon Stock 2,810 $36.48 $102,506.55
Disclosure

SEC source: 0001209191-21-018935 · doc4.xml · nonDerivative · entry 2

Beaurang Pierre · CIK 0001817226 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,690

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $35.93 and the highest price at which shares were sold was $36.91. The reporting person undertakes to provide upon request to the staff of the Securities Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.

Read SEC document
March 08, 2021 Filed Mar 9, 2021 16:04 UTC
Beaurang PierreChief Business Officer
Exercise / conversionCommon Stock 7,500 $0.84 $6,300.00
Disclosure

SEC source: 0001209191-21-018935 · doc4.xml · nonDerivative · entry 1

Beaurang Pierre · CIK 0001817226 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

Read SEC document
March 01, 2021 Filed Mar 2, 2021 22:29 UTC
Hansen GwennChief Scientific Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 800 $0.00 Strike: $7.26 $0.00
Disclosure

SEC source: 0001209191-21-016301 · doc4.xml · derivative · entry 3

Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,066

Underlying: Common Stock · 800 shares

Expires 2030-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F3 · derivative.exercise_date: The stock option vests as to 1/48 of the total shares monthly beginning February 18, 2020 until the option is fully vested on January 18, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
March 01, 2021 Filed Mar 2, 2021 22:29 UTC
Hansen GwennChief Scientific Officer
SaleCommon Stock 800 $35.95 $28,760.00
Disclosure

SEC source: 0001209191-21-016301 · doc4.xml · nonDerivative · entry 2

Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,804

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2 · balance_after: Includes 1,804 shares of Common Stock acquired by the Reporting Person on February 12, 2021 pursuant to the Issuer's employee stock purchase plan.

Read SEC document
March 01, 2021 Filed Mar 2, 2021 22:29 UTC
Hansen GwennChief Scientific Officer
Exercise / conversionCommon Stock 800 $7.26 $5,808.00
Disclosure

SEC source: 0001209191-21-016301 · doc4.xml · nonDerivative · entry 1

Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,604

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2 · balance_after: Includes 1,804 shares of Common Stock acquired by the Reporting Person on February 12, 2021 pursuant to the Issuer's employee stock purchase plan.

Read SEC document
February 24, 2021 Filed Feb 25, 2021 21:18 UTC
van Houte HansChief Financial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,829 $0.00 Strike: $7.26 $0.00
Disclosure

SEC source: 0001209191-21-014307 · doc4.xml · derivative · entry 7

van Houte Hans · CIK 0001817217 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,504

Underlying: Common Stock · 1,829 shares

Expires 2030-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F4 · derivative.exercise_date: The stock option vests as to 1/48 of the total shares monthly beginning February 18, 2020 until the option is fully vested on January 18, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
February 24, 2021 Filed Feb 25, 2021 21:18 UTC
van Houte HansChief Financial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 13,197 $0.00 Strike: $1.86 $0.00
Disclosure

SEC source: 0001209191-21-014307 · doc4.xml · derivative · entry 6

van Houte Hans · CIK 0001817217 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,136

Underlying: Common Stock · 13,197 shares

Expires 2029-08-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F3 · derivative.exercise_date: The stock option vests as to 1/48 of the total shares monthly beginning June 10, 2019 until the option is fully vested on May 10, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
February 24, 2021 Filed Feb 25, 2021 21:18 UTC
van Houte HansChief Financial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 20,393 $0.00 Strike: $1.20 $0.00
Disclosure

SEC source: 0001209191-21-014307 · doc4.xml · derivative · entry 5

van Houte Hans · CIK 0001817217 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,027

Underlying: Common Stock · 20,393 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2 · derivative.exercise_date: The stock option vests as to 1/48 of the total shares monthly beginning February 2, 2018 until the option is fully vested on January 2, 2022, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
February 24, 2021 Filed Feb 25, 2021 21:18 UTC
van Houte HansChief Financial Officer
SaleCommon Stock 35,419 $39.90 $1,413,218.10
Disclosure

SEC source: 0001209191-21-014307 · doc4.xml · nonDerivative · entry 4

van Houte Hans · CIK 0001817217 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

Read SEC document
February 24, 2021 Filed Feb 25, 2021 21:18 UTC
van Houte HansChief Financial Officer
Exercise / conversionCommon Stock 1,829 $7.26 $13,278.54
Disclosure

SEC source: 0001209191-21-014307 · doc4.xml · nonDerivative · entry 3

van Houte Hans · CIK 0001817217 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,419

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

Read SEC document
February 24, 2021 Filed Feb 25, 2021 21:18 UTC
van Houte HansChief Financial Officer
Exercise / conversionCommon Stock 13,197 $1.86 $24,546.42
Disclosure

SEC source: 0001209191-21-014307 · doc4.xml · nonDerivative · entry 2

van Houte Hans · CIK 0001817217 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,590

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

Read SEC document
February 24, 2021 Filed Feb 25, 2021 21:18 UTC
van Houte HansChief Financial Officer
Exercise / conversionCommon Stock 20,393 $1.20 $24,471.60
Disclosure

SEC source: 0001209191-21-014307 · doc4.xml · nonDerivative · entry 1

van Houte Hans · CIK 0001817217 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,393

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

Read SEC document
February 22, 2021 Filed Feb 23, 2021 23:04 UTC
van Houte HansChief Financial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 3,913 $0.00 Strike: $1.20 $0.00
Disclosure

SEC source: 0001209191-21-013353 · doc4.xml · derivative · entry 5

van Houte Hans · CIK 0001817217 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,420

Underlying: Common Stock · 3,913 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F4 · derivative.exercise_date: The stock option vests as to 1/48 of the total shares monthly beginning February 2, 2018 until the option is fully vested on January 2, 2022, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
February 22, 2021 Filed Feb 23, 2021 23:04 UTC
van Houte HansChief Financial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,417 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001209191-21-013353 · doc4.xml · derivative · entry 4

van Houte Hans · CIK 0001817217 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,333

Underlying: Common Stock · 1,417 shares

Expires 2026-04-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F3 · derivative.exercise_date: The option is fully vested.

Read SEC document
February 22, 2021 Filed Feb 23, 2021 23:04 UTC
van Houte HansChief Financial Officer
SaleCommon Stock 5,330 $39.93 $212,839.16
Disclosure

SEC source: 0001209191-21-013353 · doc4.xml · nonDerivative · entry 3

van Houte Hans · CIK 0001817217 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $39.90 and the highest price at which shares were sold was $40.03. The reporting person undertakes to provide upon request to the staff of the Securities Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

Read SEC document
February 22, 2021 Filed Feb 23, 2021 23:04 UTC
van Houte HansChief Financial Officer
Exercise / conversionCommon Stock 3,913 $1.20 $4,695.60
Disclosure

SEC source: 0001209191-21-013353 · doc4.xml · nonDerivative · entry 2

van Houte Hans · CIK 0001817217 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,330

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

Read SEC document
February 22, 2021 Filed Feb 23, 2021 23:04 UTC
van Houte HansChief Financial Officer
Exercise / conversionCommon Stock 1,417 $0.84 $1,190.28
Disclosure

SEC source: 0001209191-21-013353 · doc4.xml · nonDerivative · entry 1

van Houte Hans · CIK 0001817217 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,417

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 21:07 UTC
Hansen GwennChief Scientific Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 800 $0.00 Strike: $7.26 $0.00
Disclosure

SEC source: 0001209191-21-012662 · doc4.xml · derivative · entry 4

Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,866

Underlying: Common Stock · 800 shares

Expires 2030-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F4 · derivative.exercise_date: The stock option vests as to 1/48 of the total shares monthly beginning February 18, 2020 until the option is fully vested on January 18, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 21:07 UTC
Hansen GwennChief Scientific Officer
SaleCommon Stock 200 $37.67 $7,534.00
Disclosure

SEC source: 0001209191-21-012662 · doc4.xml · nonDerivative · entry 3

Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F3 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $37.30 and the highest price at which shares were sold was $38.04.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 21:07 UTC
Hansen GwennChief Scientific Officer
SaleCommon Stock 600 $35.81 $21,484.02
Disclosure

SEC source: 0001209191-21-012662 · doc4.xml · nonDerivative · entry 2

Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,200

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $35.38 and the highest price at which shares were sold was $36.11. The reporting person undertakes to provide upon request to the staff of the Securities Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 21:07 UTC
Hansen GwennChief Scientific Officer
Exercise / conversionCommon Stock 800 $7.26 $5,808.00
Disclosure

SEC source: 0001209191-21-012662 · doc4.xml · nonDerivative · entry 1

Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,800

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 21:08 UTC
Ring ChristineGeneral Counsel
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 2,000 $0.00 Strike: $1.86 $0.00
Disclosure

SEC source: 0001209191-21-012664 · doc4.xml · derivative · entry 5

Ring Christine · CIK 0001817199 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,666

Underlying: Common Stock · 2,000 shares

Expires 2029-09-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F5 · derivative.exercise_date: The option vests as to 1/4 of the total shares on September 9, 2020, and then 1/48 of the total shares will vest monthly thereafter until the option is fully vested on August 9, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 21:08 UTC
Ring ChristineGeneral Counsel
SaleCommon Stock 500 $37.03 $18,516.00
Disclosure

SEC source: 0001209191-21-012664 · doc4.xml · nonDerivative · entry 4

Ring Christine · CIK 0001817199 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F4 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $36.46 and the highest price at which shares were sold was $37.30.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 21:08 UTC
Ring ChristineGeneral Counsel
SaleCommon Stock 1,100 $35.86 $39,444.35
Disclosure

SEC source: 0001209191-21-012664 · doc4.xml · nonDerivative · entry 3

Ring Christine · CIK 0001817199 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F3 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $35.42 and the highest price at which shares were sold was $36.41.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 21:08 UTC
Ring ChristineGeneral Counsel
SaleCommon Stock 400 $34.48 $13,790.00
Disclosure

SEC source: 0001209191-21-012664 · doc4.xml · nonDerivative · entry 2

Ring Christine · CIK 0001817199 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,600

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $33.88 and the highest price at which shares were sold was $34.85. The reporting person undertakes to provide upon request to the staff of the Securities Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 21:08 UTC
Ring ChristineGeneral Counsel
Exercise / conversionCommon Stock 2,000 $1.86 $3,720.00
Disclosure

SEC source: 0001209191-21-012664 · doc4.xml · nonDerivative · entry 1

Ring Christine · CIK 0001817199 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 16:06 UTC
Beaurang PierreChief Business Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 2,096 $0.00 Strike: $9.57 $0.00
Disclosure

SEC source: 0001209191-21-012661 · doc4.xml · derivative · entry 11

Beaurang Pierre · CIK 0001817226 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,678

Underlying: Common Stock · 2,096 shares

Expires 2030-06-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F9 · derivative.exercise_date: The stock option vests as to 1/48 of the total shares monthly beginning June 28, 2020 until the option is fully vested on May 28, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 16:06 UTC
Beaurang PierreChief Business Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 3,797 $0.00 Strike: $7.26 $0.00
Disclosure

SEC source: 0001209191-21-012661 · doc4.xml · derivative · entry 10

Beaurang Pierre · CIK 0001817226 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,869

Underlying: Common Stock · 3,797 shares

Expires 2030-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F8 · derivative.exercise_date: The stock option vests as to 1/48 of the total shares monthly beginning February 18, 2020 until the option is fully vested on January 18, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 16:06 UTC
Beaurang PierreChief Business Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 9,107 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001209191-21-012661 · doc4.xml · derivative · entry 9

Beaurang Pierre · CIK 0001817226 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,226

Underlying: Common Stock · 9,107 shares

Expires 2026-01-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F7 · derivative.exercise_date: The option is fully vested.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 16:06 UTC
Beaurang PierreChief Business Officer
SaleCommon Stock 400 $37.88 $15,150.00
Disclosure

SEC source: 0001209191-21-012661 · doc4.xml · nonDerivative · entry 8

Beaurang Pierre · CIK 0001817226 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F6 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $37.74 and the highest price at which shares were sold was $38.01.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 16:06 UTC
Beaurang PierreChief Business Officer
SaleCommon Stock 1,000 $36.92 $36,924.00
Disclosure

SEC source: 0001209191-21-012661 · doc4.xml · nonDerivative · entry 7

Beaurang Pierre · CIK 0001817226 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F5 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $36.58 and the highest price at which shares were sold was $37.30.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 16:06 UTC
Beaurang PierreChief Business Officer
SaleCommon Stock 6,400 $35.99 $230,328.32
Disclosure

SEC source: 0001209191-21-012661 · doc4.xml · nonDerivative · entry 6

Beaurang Pierre · CIK 0001817226 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,400

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F4 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $35.53 and the highest price at which shares were sold was $36.50.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 16:06 UTC
Beaurang PierreChief Business Officer
SaleCommon Stock 4,553 $35.02 $159,453.80
Disclosure

SEC source: 0001209191-21-012661 · doc4.xml · nonDerivative · entry 5

Beaurang Pierre · CIK 0001817226 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,800

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F3 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $34.52 and the highest price at which shares were sold was $35.50.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 16:06 UTC
Beaurang PierreChief Business Officer
SaleCommon Stock 2,647 $34.19 $90,495.64
Disclosure

SEC source: 0001209191-21-012661 · doc4.xml · nonDerivative · entry 4

Beaurang Pierre · CIK 0001817226 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,353

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $33.51 and the highest price at which shares were sold was $34.46. The reporting person undertakes to provide upon request to the staff of the Securities Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5) and (6) to this Form 4.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 16:06 UTC
Beaurang PierreChief Business Officer
Exercise / conversionCommon Stock 2,096 $9.57 $20,058.72
Disclosure

SEC source: 0001209191-21-012661 · doc4.xml · nonDerivative · entry 3

Beaurang Pierre · CIK 0001817226 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 16:06 UTC
Beaurang PierreChief Business Officer
Exercise / conversionCommon Stock 3,797 $7.26 $27,566.22
Disclosure

SEC source: 0001209191-21-012661 · doc4.xml · nonDerivative · entry 2

Beaurang Pierre · CIK 0001817226 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,904

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 16:06 UTC
Beaurang PierreChief Business Officer
Exercise / conversionCommon Stock 9,107 $0.84 $7,649.88
Disclosure

SEC source: 0001209191-21-012661 · doc4.xml · nonDerivative · entry 1

Beaurang Pierre · CIK 0001817226 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,107

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 21:09 UTC
van Houte HansChief Financial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 13,583 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001209191-21-012668 · doc4.xml · derivative · entry 7

van Houte Hans · CIK 0001817217 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,750

Underlying: Common Stock · 13,583 shares

Expires 2026-01-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F7 · derivative.exercise_date: The option is fully vested.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 21:09 UTC
van Houte HansChief Financial Officer
SaleCommon Stock 400 $38.05 $15,219.00
Disclosure

SEC source: 0001209191-21-012668 · doc4.xml · nonDerivative · entry 6

van Houte Hans · CIK 0001817217 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F6 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $37.74 and the highest price at which shares were sold was $38.43.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 21:09 UTC
van Houte HansChief Financial Officer
SaleCommon Stock 666 $36.91 $24,581.26
Disclosure

SEC source: 0001209191-21-012668 · doc4.xml · nonDerivative · entry 5

van Houte Hans · CIK 0001817217 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F5 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $36.72 and the highest price at which shares were sold was $37.30.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 21:09 UTC
van Houte HansChief Financial Officer
SaleCommon Stock 5,725 $36.00 $206,109.16
Disclosure

SEC source: 0001209191-21-012668 · doc4.xml · nonDerivative · entry 4

van Houte Hans · CIK 0001817217 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,066

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F4 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $35.62 and the highest price at which shares were sold was $36.62.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 21:09 UTC
van Houte HansChief Financial Officer
SaleCommon Stock 3,652 $35.10 $128,200.54
Disclosure

SEC source: 0001209191-21-012668 · doc4.xml · nonDerivative · entry 3

van Houte Hans · CIK 0001817217 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,791

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F3 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $34.60 and the highest price at which shares were sold was $35.57.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.